This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA was retained to provide expert witness testimony in litigation on behalf of a manufacturer as part of a Lanham Act and RICO case involving the alleged sale of counterfeit drugs.
CRA calculated the lost profits due to the manufacturer for the counterfeit drug products sold and distributed by the defendants. CRA’s analysis assisted counsel for the manufacturer in settlement negotiations.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comIn this article titled “Smallest saleable patent-practicing unit in life sciences disputes,” author Erin McDermott examines methods for calculating damages in...
Antitrust Economics for Lawyers, published by LexisNexis and written by CRA consultants and affiliated experts, is geared towards attorneys in antitrust...
